CWBR Stock, CohBar Inc. Information

CohBar, Inc. OTCQX: CWBR and TSXV: COB.U is an innovative biotechnology company focused on the research and development of mitochondria based therapeutics MBTs , an emerging class of drugs for the treatment of age related diseases. MBTs originate from the discovery by CohBar s founders of a novel group of peptides within the mitochondrial genome which regulate metabolism and cell death, and whose biological activity declines with age. CohBar s efforts focus on the development of these mitochondrial derived peptides MDPs into clinically relevant MBTs that offer the potential to address a broad range of age related diseases, including NASH, obesity, type diabetes, cancer, cardiovascular and neurodegenerative diseases. To date, the Company and its founders have discovered more than MDPs.